ArticleMolecular therapy oncolytics2023

Adenovirotherapy delivering cross-hybrid IgGA Fc engineering PD-L1 inhibitors for enhanced cancer immunotherapy.

Guo Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.